- $92.38m
- $92.95m
- 35
- 64
- 19
- 32
Annual balance sheet for Nukkleus, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2022 September 30th | C2023 September 30th | 2024 September 30th | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | 10-K | 10-KT | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | 0.364 | 0.008 | 0.004 |
| Net Total Receivables | 0.966 | — | 0.035 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 3.69 | 2.93 | 0.966 |
| Net Intangible Assets | |||
| Long Term Investments | |||
| Total Assets | 18.4 | 3.35 | 0.985 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 7.47 | 9.12 | 7.07 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 7.47 | 9.55 | 8.08 |
| Non Redeemable Preferred Stock | |||
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | 10.9 | -6.19 | -7.1 |
| Total Liabilities & Shareholders' Equity | 18.4 | 3.35 | 0.985 |
| Total Common Shares Outstanding |